Blood transfusions save the lives of millions of heart surgery patients and others each year. But a new study suggests that patients who receive transfusions during heart bypass surgery have a higher risk of developing potentially dangerous infections, and dying, after their operation.In fact, this ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Vical Incorporated (Nasdaq: VICL) announced today the initiation of a Phase 3 pivotal trial of the company's Allovectin-7(R) cancer immunotherapeutic as first-line therapy in chemotherapy-naive patients with recurrent Stage III or IV metastatic melanoma. The trial, known as AIMM (Allovectin-7(R) Im...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Although it "doesn't take much to save the life of a person living with HIV," there are 40 million people living with HIV worldwide, which means there are "40 million lives that need saving," Laurent Fischer, who serves on the board of the AIDS Healthcare Foundation, writes in a San Jose Mercury New...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Alimera Sciences Inc., an ophthalmic pharmaceutical company founded just three years ago, today announced that the U. S. Food and Drug Administration (FDA) has approved its ophthalmic solution Rx-to-OTC-switch new drug application (NDA) for Alaway(TM) (ketotifen fumarate ophthalmic solution 0.025%)....
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The exploration of dementia will continue at the Indiana University School of Medicine with the renewal of a National Institutes of Health grant for $7.3 million to fund the Indiana Alzheimer Disease Center. This is the fourth renewal of the original center grant which was awarded in 1991. [click li...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The hustle and bustle of the holiday season is in full swing. As the end of the year quickly approaches, people often overexert themselves to find the perfect last minute gifts, to prepare complicated holiday meals or to graciously entertain even the most difficult guests. Bruce Spring, M.D. [click ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
By joining a sugar to a short-chain fatty acid compound, Johns Hopkins researchers have developed a two-pronged molecular weapon that kills cancer cells in lab tests. The researchers cautioned that their double-punch molecule, described in the journal Chemistry & Biology, has not yet been tested on ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.